HCW Biologics Inc. (HCWB) Operating income 2020–2025
HCW Biologics Inc. (HCWB) annual operating income history from SEC filings — each fiscal year as reported.
-$13.2MFY2025 · since FY2020: -$5.8M → -$13.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.2M | +55.3% |
| FY2024 | -$29.5M | -14.5% |
| FY2023 | -$25.7M | -70.6% |
| FY2022 | -$15.1M | -12.8% |
| FY2021 | -$13.4M | -129.5% |
| FY2020 | -$5.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HCWB financial trends
HCWB RevenueHCWB Net incomeHCWB Net marginHCWB Gross profitHCWB Gross marginHCWB Operating marginHCWB Operating cash flowHCWB Free cash flowHCWB Capital expendituresHCWB Return on equityHCWB Stock buybacksHCWB Dividends paidHCWB Total assetsHCWB Total liabilitiesHCWB Shareholders’ equityHCWB overview →